Vaccination with trivalent live attenuated versus inactivated influenza vaccine in children aged 2 to 17 years is cost saving or cost-effective depending on the severity of the influenza season.
Timothy M. Klein, BS
Advertisement
Articles by Timothy M. Klein, BS
Advertisement
Latest Updated Articles
- Cost-Effectiveness of Live Attenuated Versus Inactivated Influenza Vaccine Among Children
Published: August 20th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
Accelerated Approval of Cancer Drugs: Benefit or Burden?
3
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
4
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
5
